SCHEMBL7908175

SCHEMBL7908175

CSc1ccc(OC(F)(F)[C@H](C)N[C@@H](CSCc2cccnc2)C(=O)O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE P12821 6/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
MMP1 P03956 2/20 0.41
MMP9 P14780 2/20 0.41
MMP13 P45452 2/20 0.41
ADAM17 P78536 2/20 0.41
GPR132 Q9UNW8 2/20 0.41
PPARG P37231 1/20 0.38
PPARA Q07869 1/20 0.38
EDNRB P24530 1/20 0.37
EDNRA P25101 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
CYP3A4 P08684 1/20 0.36
POLB P06746 1/20 0.36
HPGD P15428 1/20 0.36
ABL1 P00519 1/20 0.36
OPRM1 P35372 1/20 0.36
KCNH2 Q12809 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15062927 0.88 MMP1 (0.43) ACEMEN1KMT2AMMP1MMP9
SCHEMBL15062926 0.88 MMP1 (0.43) ACEMEN1KMT2AMMP1MMP9
SCHEMBL15062860 0.87 ACE (0.42) ACEMEN1KMT2AMMP1MMP9
SCHEMBL15063008 0.80 MMP1 (0.39) ACEMEN1KMT2AMMP1MMP9
SCHEMBL15063006 0.80 MMP1 (0.39) ACEMEN1KMT2AMMP1MMP9
SCHEMBL2344921 0.77 GPR132 (0.42) ACEKMT2AMMP1MMP9MMP13
SCHEMBL14686198 0.74 KDM4E (0.40) ACEMMP1MMP9MMP13ADAM17
SCHEMBL1272373 0.73 FOLH1 (0.43) ACEGPR132RAB9APOLB
SCHEMBL1272374 0.73 FOLH1 (0.43) ACEGPR132RAB9APOLB
SCHEMBL15062930 0.71 CTSL (0.38) MEN1KMT2AMMP1MMP9MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010056877-A2 HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS VIROBAY, INC. (US) 2010-05-20 WO disclosed